Dr. Allan Hildesheim, senior investigator and former chief of the Infections and Immunoepidemiology Branch, retired from NCI’s Division of Cancer Epidemiology and Genetics after 33 years of service.
Dr. Deborah Winn, senior advisor to the director of the Division of Cancer Prevention (DCP), and who served as acting director of the division from January 2019 to July 2020, is retiring at the end of January 2021.
Dr. Jennifer Loud, adult nurse practitioner and assistant chief in the Clinical Genetics Branch (CGB), Division of Cancer Epidemiology and Genetics (DCEG), retired in August after 27 years of service to the National Cancer Institute.
Dr. Tilda Farhat has been named director of the Office of Strategic Planning, Legislation and Scientific Policy at the National Institute on Minority Health and Health Disparities.
Dr. Neil Caporaso, an internationally recognized expert in genetic and environmental factors influencing lung cancer, chronic lymphocytic leukemia (CLL) and related familial hematologic disorders, retired from the National Cancer Institute’s Division of Cancer Epidemiology and Genetics in October.
Dr. Mary Kay Floeter, a senior clinician in the motor neuron disorders unit in the Neurogenetics Branch of NINDS’s Division of Intramural Research, retired Sept. 30 after 30 years of federal service—all with NINDS.